z-logo
open-access-imgOpen Access
JAK1/2 Inhibitors Linked to Aggressive B-cell Lymphoma Risk in Myelofibrosis and Pre-existing B-cell Clones May Mark Those at Risk
Author(s) -
Sioḃán Keel
Publication year - 2018
Publication title -
the hematologist
Language(s) - English
Resource type - Journals
ISSN - 1551-8779
DOI - 10.1182/hem.v15.5.8922
Subject(s) - myelofibrosis , cancer research , lymphoma , oncology , cell , b cell , medicine , b cell lymphoma , biology , genetics , immunology , bone marrow , antibody

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom